The Canadian Partnership Against Cancer is
proud to collaborate with Current Oncology to present a special supplement on
Canada-specific cancer costing and economic evaluation research.
Our unique health care system requires specifically Canadian studies to effectively evaluate cost differences and variability in individual interventions, care pathways and cancer care systems. Economic research is highly useful for identifying good value and high quality care, but there is an acute shortage of Canada-specific evidence available. As a result, decision makers cannot accurately assess the impact of new processes, practices and technologies to make decisions of most benefit to Canadians.
The Current Oncology supplement helps fill this gap by showcasing the work of researchers focused on answering questions pertinent to Canadian cancer control. Read more here.
Our unique health care system requires specifically Canadian studies to effectively evaluate cost differences and variability in individual interventions, care pathways and cancer care systems. Economic research is highly useful for identifying good value and high quality care, but there is an acute shortage of Canada-specific evidence available. As a result, decision makers cannot accurately assess the impact of new processes, practices and technologies to make decisions of most benefit to Canadians.
The Current Oncology supplement helps fill this gap by showcasing the work of researchers focused on answering questions pertinent to Canadian cancer control. Read more here.
No comments:
Post a Comment